Anymedi Inc. (XKON:390110)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,489.00
-2.00 (-0.13%)
At close: Jul 29, 2025, 3:30 PM KST

Anymedi Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2021FY 2020FY 2019
Period Ending
Dec '21 Dec '20 Dec '19
Operating Revenue
334.34131.7583.51
Other Revenue
---0
334.34131.7583.51
Revenue Growth (YoY)
153.78%57.77%-
Cost of Revenue
650.05248.69588.53
Gross Profit
-315.71-116.94-505.03
Selling, General & Admin
3,7331,600993.45
Research & Development
3,0441,602724.15
Other Operating Expenses
47.4630.1214.68
Operating Expenses
7,5553,6231,807
Operating Income
-7,871-3,739-2,312
Interest Expense
-359.69-330.1-6.7
Interest & Investment Income
25.999.163.01
Other Non Operating Income (Expenses)
-2,953-481.5733.61
EBT Excluding Unusual Items
-11,158-4,542-2,282
Gain (Loss) on Sale of Assets
-0.13-13.47-
Pretax Income
-11,158-4,555-2,282
Net Income
-11,158-4,555-2,282
Net Income to Common
-11,158-4,555-2,282
Shares Outstanding (Basic)
650
Shares Outstanding (Diluted)
650
Shares Change (YoY)
16.83%4900.13%-
EPS (Basic)
-1998.00-953.00-23875.20
EPS (Diluted)
-1998.00-953.00-23875.20
Free Cash Flow
-7,543-7,378-2,188
Free Cash Flow Per Share
-1350.75-1543.42-22887.10
Gross Margin
-94.43%-88.76%-
Operating Margin
-2354.10%-2838.39%-2769.08%
Profit Margin
-3337.30%-3457.75%-2733.25%
Free Cash Flow Margin
-2256.19%-5599.97%-2620.13%
EBITDA
-6,888-3,165-2,094
D&A For EBITDA
982.42574.85218
EBIT
-7,871-3,739-2,312
Advertising Expenses
999.74262.27202.89
Source: S&P Global Market Intelligence. Standard template. Financial Sources.